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wines, both-white and red, are an excellent source of salicylic 
acid and its metabolites, 2,3-dihydroxybenzoic acid (DHB), 
and 2,5-DHB, both of which have proven vasodilator and 
anti-inflammatory activities, in addition to other health- 
related functions. Many plants, in additiyn to grapes, 
produce salicylic acid. It is produced in plants as a 
constitutive and as an inducible defence yhemical. Indeed, 
salicylic acid is so common that it has been postulated to be 
We have determined concentrauqhs of salicylic acid, 
2,3-DHB, and 2,j-DHB in several. Californian and other 
wines. Salicylic acid concentration$‘ ranged from 114-21-5 
m a ,  2,3-DHB 21.0-26-5 mg/L.?and 2,j-DHB 22-0-28.5 
m g L 5  As expected, highen: concentrations of each 
compound are present in red $ne,. Even in white wines, the 
total of these compounds ppr litre of wine is, on average, 
equivalent to almost double the widely recommended daily 
dose of 30 mg of aspirin td maintain cardiovascular wellness. 
In addition, because id wine salicylic acid (and other 
antioxidants) coexist q t h  ethanol, synergistic effects among 
these substances piay have an increasing role in 
cardiovascular welly&. It is conceivable that ethanol might 
enhance general antioxidant absorption from the intestinal 
lumen as well. Furthermore, detoxification of ethanol to 
acetate by the Jiver (and to a lesser extent in other organs) 
produces reducing equivalents (reduced nicotinamide- 
adenine diducleotide) in profusion. These reducing 
equivalents ((either directly or indirectly) aid in maintaining 
any ingeqld antioxidants in their reduced state as well as in 
recyclin$ spent antioxidants (which could conceivably be 
dama %g as pro-oxidants) . 
In onclusion, those of us who are entrusted with the 
privi ege of prescribing, might well do so as: “Take two 
ia4ogenic-related complaints would be eliminated. 
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glas 1 es of wine and see me in the moming”. Surely then, 
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Diagnosing growth-gbrmone deficiency in 
adults P’ 
SIR-Hoffman and,pÓlleagues (April 30, p 1064) conclude 
that the insulin tolerance test (ITT) is the test of choice in 
inly based on a comparison of ITT 
concentration (72 pooled samples). 
us arginine or clonidine, heat exposure). 
are negative determinants of spontaneous 
nd GH release in respons%/ to stimuli. 
ntrol group aged up to 78 yea‘rs and having 
response to stimulation tests. 
We are not told how many controls underwent both 
investigations. Hoffman et al stress that a single GH profile 
lacks diagno$ic specificity because of intra-individual , 4 
variation up to 3OYL However, the intra-individual variation 
in ITT may be at least as great in adultsi~* and in children3 
and this measure does ‘not necessarily reflect physiolo@cal 
spontaneous 24 h GH secretion.a 
The wide variation in response to pharmacologicaIr&muli 
must also call in question the usefulness ,of those 
investigations. A thorough investigation of the p?$siological 
spontaneous pulsatile GH secretion demands{,several GH 
measurements over 24 h, a sensitive GH assay, and the use 
of computerised algorithms and/or a 9 deconvolution 
technique. Diagnosing GH deficiency i? “idults cannot be 
based on a single non-physiological testguch as the ITT or a 
mean 24 h serum GH. A diagnosis oS.GH deficiency, which 
could lead to life-long treatment, n$st be based on at least 
two diagnostic tests, possiblyi‘including physiological 
(spontaneous) GH secretion. 
I 
Michael Hdby Rasmussen, Jann 
Denmark R 
Department of Endocrinology. Hvidovre Ukiversity Hospital, DK-2650 Hvidovre, 
it 
P 
hormone response to insulin I in control 
1 
Antiretroviral prevention of HIV perinatal 
transmission 
SIR-In the AIDS Clinical Trials Group study 076 (ACTG 
076) interim analysis established that the risk of transmission 
from mother to child in those taking zidovudine was reduced 
by two-thirds, as Cho0 reports in your Feb 26 news item. 
Prenatal and postnatal administration of zidovudine may 
soon become standard prevention strategy in industrialised 
countries. 
The full lessons of ACTG 076 have yet to be learned. 
How did zidovudine work, for example, and would a 
different regimen have been even more effective? The 
most pressing questions, however, relate to the developing 
world, where up to 98% of the nearly 10 million women 
infected with HIV and where almost all of the more than 2 
million perinatally infected infants 1ive.l Are there 
differences, for example, in maternal nutrition, metabolism, 
health status, or birthing practices that might affect drug 
safety and efficacy in these settings? H N  subtype B 
predominates in North America and Europe, but will 
zidovudine be as effective for the other H N  subtypes that 
prevail in Africa and Asia? 
Conditions in many developing countries (limited access 
to antenatal care, delivery under less than optimum 
conditions, and very brief stays in maternity units) differ 
greatly from those under which ACTG 076 was conducted. 
For antiretroviral protocols to be adapted for the developing 
world, rigorous clinical trials will be required. Ethical issues 
would be important. For example, does the fact that most 
HIV-infected women in the developing world have no access 
to zidovudine, or even to more basic drugs, justify placebo- 
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controlled trials of a less expensive and shortened course of 
antiretroviral therapy? Will several trials be necessary to 
allow for virus strain variations and differences in culture, 
behaviour, and health care system? Most infected mothers in 
developing countries only leam of their HIV status because 
they have given birth to an infected infant. The drastic 
expansion of voluntary testing and counselling services, the 
availability of informed reproductive options, and the 
protection of confidentiality-particularly for those who 
received aidovudine during pregnancy or after birth, which is 
indicative of HIV status-need to be reassessed in the light 
of a proven, life-saving strategy having become available. 
Economic disparities are also of concern. The cost of 
medication alone for ACTG 076 was about US$600 per 
mother-and-child pair which is a prohibitive cost for most 
developing economies. 
ACTG 076 is one of the rare successes in HIVclinical 
research that has immediate application potential. This 
discovery is most directly and unequivocally relevant to the 
developing world. Only the rights-clearly spelled out in the 
International Bill of Human Rights*--of people throughout 
the world to benefit from scientific progress will provide us 
with the power to overcome the obstacles ahead. 
No one institution can be expected to meet the challenges 
alone. The scientific community has to continue to 
aggressively seek answers to the crucial issues raised by 
ACTG 076. National authorities should assess the policy, 
strategic, and economic implications of the new findings and 
both curb perinatal transmission and expand prenatal and 
posmatal care. International health organisations have to 
move swiftly to ensure that unfolding knowledge is widely 
shared and that this new prevention tool is affordable and 
sustainable in all situations. Drug manufacturers and 
intemational agencies, now facing a situation in which the 
access of developing countries to antiretrovirals can greatly 
affect the pandemic, must assist in the development, 
distribution, and effective use of their products. 
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HIV iookback a forward glance? 
SIR-In your March 26 editorial (p 744):filliscussing UK 
policy on the management of HIV$fected healthcare 
workers, you make selective use of &ailable information, 
and fail to make several important p in ts .  
A reader might interpret the,.&atement that, in the one 
instance where HW traymission from an infected 
healthcare worker to patierp has been reliably recorded the 
route of transmission i spc lear ,  as casting a doubt on the 
need for specific preyntion. However, it is not necessary 
(though it may ,&‘ desirable) to 
mechanism by ;,&ch transmission 
demonstrate $?t’a risk of transmission 
explanation ,.;i% to precisely how hepatitis B virus is 
transmitteF.,’; to patients by hepatitis B-e-antigen-positive 
health-cate workers during exposure-prone procedures in 
the ab&nce of overt injury to the worker did not preclude 
the dCvelopment of a prevention p01icy.~ Recent insights into 
* 
d 
- 
the eafe with which handling suture matei,d may lead to 
inapparent i n j e  have merely strengthepgd the case for 
restriction of practice. 
As you stare, the UK professional &datory bodies do 
indeed require that HW-infected heilk-care workers seek 
medical and occupational health a dice. More importantly, 
may have been exposed to infesfron with HIV , i n whatever, 
must seek mjaical advice and diagnostic 
g if appropri$e. Fulfilment of these ethical 
obviates th-6 necessity for an alternative 
- 
though, they also require that t h x e  9 who believe that they 
1( 
response is unlikely because most pafients who have 
undergone exposure-prone procedures il1 not have major 
risk factors for HIVinfection, but will d e in, and likely to 
remain in, monogamous heterosex& relationships,f and 
may correctly perceive that theirtrisks of a sexually 
transmitted infection are low. If suc$ patients have acquired 
HIV infection they will benefit fro@ this knowledge because 
it will enable them to take actio3 to protect their partner. 
Onward transmission could be ?!evenred if their infection is 
recognised through initiationbof an HIV test by care 
k providers. 
1 
I 
. , 
reporting AIDS cases and HIV 
clinicains and microbiologists who 
able Disease Surveillance Centre in 
e datasets held nationally. 
ptonstall, Ahilya Noone, Janet Mortimer 
Service. PHLS Communicable Disease Surveillance Centre. 
n AV, Wadsworth J, &’ellings K, Field J. Sexual attitudes 
-styles. Oxford Blackwell Scientific Publications, 
199‘4. 
1430 
~ ~ 
Vol 343 -June 4, 1994 
